Financials
- Market Capitalization 264.67 M
- Employee 214
- Founded 2000
- CEO N/A
- Website www.eyepoint.bio
- Headquarter Delaware, United States
- FIGI BBG000F90JX5
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-5.76
ratio cours/chiffre d'affaires
0.04
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3306 | FULC Fulcrum Therapeutics, Inc. - Common Stock | 3.68 USD | -1.87% | -0.54% | -3.16% | -57.94% | 280.77 M USD | ||
| 3311 | SRZN Surrozen, Inc. - Common Stock | 23.51 USD | -5.05% | -8.91% | +32.00% | +72.49% | 276.33 M USD | ||
| 3351 | NAUT Nautilus Biotechnology, Inc. - Common Stock | 2.05 USD | -5.53% | +22.75% | +127.78% | +107.07% | 260.87 M USD | ||
| 3353 | VNDA Vanda Pharmaceuticals Inc. - Common Stock | 4.30 USD | -5.29% | -4.02% | -16.83% | -22.24% | 259.99 M USD |